Abstract:Background: Acute hepatic failure (AHF) is a devastating clinical syndrome with a high mortality rate. The outcome of AHF varies with etiology, but liver transplantation (LT) can significantly improve the prognosis and survival rate of such patients. This study aimed to detect the role of LT and artificial liver support systems (ALSS) for AHF patients and to analyze the etiology and outcome of patients with this disease. Methods: A retrospective analysis was made of 48 consecutive patients with AHF who fulfilled the Kings College Criteria for LT at our center. We analyzed and compared the etiology, outcome, prognosis, and survival rates of patients between the transplantation (LT) group and the non-transplantation (N-LT) group. Results: AHF was due to viral hepatitis in 25 patients (52.1%; hepatitis B virus in 22), drug or toxic reactions in 14 (29.2%; acetaminophen in 6), Wilson disease in 4 (8.3%), unknown reasons in 3 (6.3%), and miscellaneous conditions in 2 (4.2%). In the LT group, 36 patients (7 underwent living donor LT, and 29 cadaveric LT) had an average model for end-stage liver disease score (MELD) of 35.7. Twenty-eight patients survived with good graft function after a follow-up of 27.3+/-4.5 months. During the waiting time, 6 patients were treated with ALSS and 2 of them died during hospitalization. The 30-day, 12-month, and 18-month survival rates were 77.8%, 72.2%, and 66.7%, respectively. In the N-LT group, 12 patients had an average MELD score of 34.5. Four patients were treated with ALSS and all died during hospitalization. The 90-day and 1-year survival rates were only 16.7% and 8.3%, respectively. Conclusions: Hepatitis is the most prominent cause of AHF at our center. Most patients with AHF, who fulfill the Kings College Criteria for LT, did not survive longer without LT. ALSS did not improve the prognosis of AHF patients, but may extend the waiting time for a donor. Currently, LT is still the most effective way to improve the prognosis of AHF patients.

Treatment of acute liver failure by artificial liver in combination with liver transplantation

Efficacy of different therapeutic modalities for patients with acute-on-chronic liver failure induced by hepatitis B

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Treatment of Hepatic Failure with Artificial Liver Support System.

Artificial Liver Support System Combined With Liver Transplantation In The Treatment Of Patients With Acute-On-Chronic Liver Failure

A Single-Center Experience of Non-Bioartificial Liver Support Systems among Chinese Patients with Liver Failure

Efficacy of liver transplantation for acute hepatic failure: a single-center experience

Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver

Severe Hepatitis Treated with an Artificial Liver Support System

Clinical Evaluation of Treatment with Artificial Liver Support System in Chronic Fulminant Viral Hepatitis

Efficacy of Non-Bioartificial Liver in the Treatment of Children with Acute Liver Failure

Evaluation of a Novel Hybrid Bioartificial Liver Based on Multi-Layer Fiat-Plate Bioreactor

Research progress on the role of probiotics in acute liver failure

Artificial Liver Support and Liver Transplantation for the Treatment of Severe Hepatitis

Artificial Liver Support System in China: a Review over the Last 30 Years.

Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure

[Survival Analysis on Liver Failure Patients Treated with an Artificial Liver Support System].